Aliqopa

Bayer to withdraw follicular lymphoma therapy after trial failure
Clinical Trials Arena
Tue, 11/14/23 - 09:37 am
Bayer
Aliqopa
relapsed follicular lymphoma
clinical trials
AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in lymphoma
Fierce Pharma
Sun, 04/11/21 - 11:36 pm
AACR
Bayer
Aliqopa
non-Hodgkin lymphoma
follicular lymphoma
Zydelig
Bayer’s Aliqopa gets speedy review for marginal zone lymphoma
Pharmaforum
Wed, 05/29/19 - 09:54 am
Bayer
Aliqopa
FDA
breakthrough therapy
marginal zone lymphoma
Bayer gears up to take on Gilead in lymphoma with Aliqopa green light
Fierce Pharma
Sat, 09/16/17 - 11:58 am
Bayer
Gilead Sciences
Aliqopa
copanlisib
relapsed follicular lymphoma
Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Endpoints
Fri, 09/15/17 - 09:51 am
Bayer
FDA
Aliqopa
relapsed follicular lymphoma